摘要
超说明书用药在临床治疗中确有其必要性和合理性,在诸多现实因素的驱动下,从《处方管理办法》到《中华人民共和国医师法》第二十九条新规的出台,立法层面逐步为临床医师超说明书用药提供了法律保障。为保障患者的用药安全,医师的超说明书用药自主权又需在保障患者最佳利益、可靠的循证医学证据支持及在患者或监护人知情同意的情况下谨慎、合理用药。同时也依靠医疗机构、药师等主体的配合监督来实现安全用药。
The necessity and rationality of over instruction drug use in clinical treatment are confirmed. Driven by many practical factors,from the Prescription Management Measures to the introduction of Article 29 of the Doctor law of the People’s Republic of China,has gradually provided legal protection for clinicians’ over instruction drug use. In order to ensure the safety of patients’ medication, doctors’ autonomy of over instruction medication also needs to be cautious and reasonable in the protection of patients’ best interests, the support of reliable evidence-based medical evidence,and the informed consent of patients or guardians. At the same time,it also relies on the cooperation and supervision of medical institutions,pharmacists and other subjects to achieve safe drug use.
作者
刘颖
Liu Ying(School of Humanities and Management,Fujian University,Fuzhou 350122,China)
出处
《锦州医科大学学报（社会科学版）》
2022年第6期30-33,共4页
Journal of Jinzhou Medical University(Social Science Edition)
基金
2020年福建省中青年教师教育科研项目(社科类)一般项目“福建中医药地方立法的实践困境与制度构建研究”(编号:JAS20112)
2021年福建中医药大学校管科研课题“新《医师法》背景下超说明书用药制度研究”(编号:X2021022-重点)的研究成果。
关键词
《医师法》
超说明书用药
知情同意权
Doctor law of the People’s Republic of China
right to informed consent for over
informed consent right
